Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Denali Therapeutics Inc (NQ: DNLI ) 27.05 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Denali Therapeutics Inc < Previous 1 2 3 Next > Denali Therapeutics Stock Is Sliding After The Bell: Here's Why October 10, 2024 Denali Therapeutics shares are moving lower in Thursday's after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued. Via Benzinga A Biotech Breakout Will Be Led By Small Caps September 23, 2024 It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. Via Talk Markets Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates DNLI Stock Earnings: Denali Therapeutics Beats EPS for Q2 2024 August 01, 2024 DNLI stock results show that Denali Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Denali Therapeutics Stock Gets Technical Rating Upgrade July 16, 2024 Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Via Investor's Business Daily 3 Longevity Stocks to Buy for Anti-Aging Breakthroughs July 08, 2024 Longevity stocks are at the forefront of combating age-related illnesses with transformative AI-driven drug discovery. Via InvestorPlace 4 Analysts Assess Denali Therapeutics: What You Need To Know February 28, 2024 Via Benzinga Denali Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga The Latest Analyst Ratings for Denali Therapeutics December 13, 2023 Via Benzinga Where Denali Therapeutics Stands With Analysts November 08, 2023 Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday May 08, 2024 Via Benzinga DNLI Stock Earnings: Denali Therapeutics Beats EPS for Q1 2024 May 07, 2024 DNLI stock results show that Denali Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Analyst Expectations for Denali Therapeutics's Future August 31, 2023 Via Benzinga Where Denali Therapeutics Stands With Analysts August 10, 2023 Via Benzinga Analyst Expectations for Denali Therapeutics's Future June 21, 2023 Within the last quarter, Denali Therapeutics (NASDAQ:DNLI) has observed the following analyst ratings: Via Benzinga To the Moon and Beyond: 7 Stocks With Cosmic Potential March 14, 2024 With the Fear and Greed Index at 69, it's an opportune to wager on these attractive Stocks with Moonshot Potential. Via InvestorPlace Goldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Know February 29, 2024 Via Benzinga Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Via Benzinga Why Shares of Denali Therapeutics Are Up Monday May 15, 2023 Analysts maintained their buy ratings on the clinical-stage biotech company. Via The Motley Fool Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday February 27, 2024 U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst February 12, 2024 Insights from Wedbush analysts about the clinical effectiveness of REGENXBIO's RGX-202, market potential, and challenges posed by competitors like Sarepta Therapeutics and Pfizer. Via Benzinga 3 Biotech Stocks to Buy for the Next Bull Run: February 2024 February 08, 2024 These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month. Via InvestorPlace 3 Biotech Stocks at the Forefront of the Quest for Eternal Youth January 02, 2024 Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today. Via InvestorPlace Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday November 03, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst September 06, 2023 B Riley Securities initiated coverage on Denali Therapeutics Inc (NASDAQ: DNLI) with a Buy rating and a Via Benzinga Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now June 29, 2023 With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga Denali Says Hunter Syndrome Candidate Lowers Disease-Associated Biomarker June 20, 2023 Denali Therapeutics Inc (NASDAQ: DNLI) announced new interim results from the ongoing open-label, single-arm Phase 1/2 study of DNL310 IDS in children with Via Benzinga Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure June 05, 2023 Via Benzinga Biogen Moves Deeper In Alzheimer's With Denali April 14, 2023 Biogen exercised their rights to a Denali Alzheimer's drug. What does this mean longer term to the field and the companies? Via Talk Markets < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
